Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 46


Notification of international normalized ratio test in atrial fibrillation patients treated with warfarin via short message service: Study protocol for a randomized controlled trial.

Sheibani R, Sheibani M, Hejazi Y, Eslami S.

Electron Physician. 2017 Jul 25;9(7):4732-4736. doi: 10.19082/4732. eCollection 2017 Jul.


SAMe-TT2R2 Score in the Outpatient Anticoagulation Clinic to Predict Time in Therapeutic Range and Adverse Events.

Pivatto Junior F, Scheffel RS, Ries L, Wolkind RR, Marobin R, Barkan SS, Amon LC, Biolo A.

Arq Bras Cardiol. 2017 Apr;108(4):290-296. doi: 10.5935/abc.20170052. English, Portuguese.


Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.

Szummer K, Gasparini A, Eliasson S, Ärnlöv J, Qureshi AR, Bárány P, Evans M, Friberg L, Carrero JJ.

J Am Heart Assoc. 2017 Mar 1;6(3). pii: e004925. doi: 10.1161/JAHA.116.004925.


Combined Acute Haemolytic and Secondary Angle Closure Glaucoma following Spontaneous Intraocular Haemorrhages in a Patient on Warfarin.

Andreatta W, Boukouvala S, Bansal A.

Case Rep Ophthalmol. 2016 Nov 14;7(3):233-238. eCollection 2016 Sep-Dec.


Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation.

Tawfik A, Bielecki JM, Krahn M, Dorian P, Hoch JS, Boon H, Husereau D, Pechlivanoglou P.

Clin Pharmacol. 2016 Aug 11;8:93-107. doi: 10.2147/CPAA.S105165. eCollection 2016.


How Well Do Stroke Risk Scores Predict Hemorrhage in Patients With Atrial Fibrillation?

Quinn GR, Singer DE, Chang Y, Go AS, Borowsky LH, Fang MC.

Am J Cardiol. 2016 Sep 1;118(5):697-9. doi: 10.1016/j.amjcard.2016.06.014. Epub 2016 Jun 15.


Polypharmacy and effects of apixaban versus warfarin in patients with atrial fibrillation: post hoc analysis of the ARISTOTLE trial.

Jaspers Focks J, Brouwer MA, Wojdyla DM, Thomas L, Lopes RD, Washam JB, Lanas F, Xavier D, Husted S, Wallentin L, Alexander JH, Granger CB, Verheugt FW.

BMJ. 2016 Jun 15;353:i2868. doi: 10.1136/bmj.i2868.


Effect of Left Ventricular Systolic Dysfunction on Response to Warfarin.

Ather S, Shendre A, Beasley TM, Brown T, Hill CE, Prabhu SD, Limdi NA.

Am J Cardiol. 2016 Jul 15;118(2):232-6. doi: 10.1016/j.amjcard.2016.04.047. Epub 2016 May 5.


Is the HAS-BLED score useful in predicting post-extraction bleeding in patients taking warfarin? A retrospective cohort study.

Kataoka T, Hoshi K, Ando T.

BMJ Open. 2016 Mar 2;6(3):e010471. doi: 10.1136/bmjopen-2015-010471.


Effectiveness and safety of dabigatran versus acenocoumarol in 'real-world' patients with atrial fibrillation.

Korenstra J, Wijtvliet EP, Veeger NJ, Geluk CA, Bartels GL, Posma JL, Piersma-Wichers M, Van Gelder IC, Rienstra M, Tieleman RG.

Europace. 2016 Sep;18(9):1319-27. doi: 10.1093/europace/euv397. Epub 2016 Feb 3.


Dabigatran is Less Effective Than Warfarin at Attenuating Mechanical Heart Valve-Induced Thrombin Generation.

Jaffer IH, Stafford AR, Fredenburgh JC, Whitlock RP, Chan NC, Weitz JI.

J Am Heart Assoc. 2015 Aug 24;4(8):e002322. doi: 10.1161/JAHA.115.002322.


Stroke and Bleeding Risk Associated With Antithrombotic Therapy for Patients With Nonvalvular Atrial Fibrillation in Clinical Practice.

An J, Niu F, Lang DT, Jazdzewski KP, Le PT, Rashid N, Meissner B, Mendes R, Dills DG, Aranda G, Bruno A.

J Am Heart Assoc. 2015 Jul 17;4(7). pii: e001921. doi: 10.1161/JAHA.115.001921.


Oral anticoagulant therapy and bleeding events with vitamin K antagonists in patients with atrial fibrillation in a Hungarian county hospital.

Mark L, Dani G, Vendrey R, Paragh G, Katona A.

Med Sci Monit. 2015 Feb 17;21:518-25. doi: 10.12659/MSM.892360.


Efficacy and safety of oral anticoagulants versus aspirin for patients with atrial fibrillation: a meta-analysis.

Zhang JT, Chen KP, Zhang S.

Medicine (Baltimore). 2015 Jan;94(4):e409. doi: 10.1097/MD.0000000000000409. Review.


Time Trends of Aspirin and Warfarin Use on Stroke and Bleeding Events in Chinese Patients With New-Onset Atrial Fibrillation.

Guo Y, Wang H, Tian Y, Wang Y, Lip GYH.

Chest. 2015 Jul;148(1):62-72. doi: 10.1378/chest.14-2018.


Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study.

Caldeira D, Cruz I, Morgado G, Stuart B, Gomes C, Martins C, João I, Pereira H.

BMC Res Notes. 2014 Dec 9;7:891. doi: 10.1186/1756-0500-7-891.


Stroke and bleeding risk in atrial fibrillation.

Senoo K, Lane D, Lip GY.

Korean Circ J. 2014 Sep;44(5):281-90. doi: 10.4070/kcj.2014.44.5.281. Review.


AREDS Formula, Warfarin, and Bleeding: A Case Report from the Michigan Anticoagulation Quality Improvement Initiative.

Puroll E, Heidt ST, Haymart B, Froehlich JB, Kline-Rogers E, Barnes GD.

Case Rep Med. 2014;2014:754147. doi: 10.1155/2014/754147. Epub 2014 Aug 28.


Management of gastrointestinal bleeding in patients anticoagulated with dabigatran compared with warfarin: a retrospective, comparative case review.

Manatsathit W, Al-Hamid H, Leelasinjaroen P, Hashmi U, McCullough PA.

Cardiovasc Diagn Ther. 2014 Jun;4(3):224-31. doi: 10.3978/j.issn.2223-3652.2014.03.07.


Effect of selective serotonin reuptake inhibitors on bleeding risk in patients with atrial fibrillation taking warfarin.

Quinn GR, Singer DE, Chang Y, Go AS, Borowsky LH, Udaltsova N, Fang MC.

Am J Cardiol. 2014 Aug 15;114(4):583-6. doi: 10.1016/j.amjcard.2014.05.037. Epub 2014 Jun 5.

Supplemental Content

Loading ...
Support Center